Rituximab treatment in resistant lupus  nephritis: A single-center prospective study

CONCLUSION: Rituximab is a safe and effective therapeutic strategy for patients with resistant LN.PMID:38660888 | DOI:10.5414/CN111104

Source: Clinical Nephrology - April 25, 2024 Category: Urology & Nephrology Authors: Shahzad Alam Mastakim Ahmed Mazumder Manjuri Sharma Pranab Jyoti Mahanta Manzoor Parry Prodip Kumar Doley Source Type: research